Lupus anticoagulant: A marker for stroke and venous thrombosis in primary Sjögren's syndrome

Clinical Rheumatology

Volumn 31, Issue 9, 2012, Pages 1331-1338

  Pasoto, Sandra Gofinet ^a   Chakkour, Henrique Pires ^a   Natalino, Renato Romera ^a   Viana, Vilma S T ^a   Bueno, Cleonice ^a   Lianza, Alessandro Cavalcanti ^a   De Andrade, José Lázaro ^a   Neto, Mauricio Levy ^a   Fuller, Ricardo ^a   Bonfa, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Deep vein thrombosis; Lupus anticoagulant; Primary Sj gren's syndrome; Stroke

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNICITY; FEMALE; HEART INFARCTION; HORMONAL CONTRACEPTION; HUMAN; HYPERTENSION; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; STRUCTURED INTERVIEW; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CARDIOLIPINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; RISK FACTORS; SJOGREN'S SYNDROME; STROKE; TIME FACTORS; VENOUS THROMBOSIS;

EID: 84867875959     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2019-z     Document Type: Article

References (38)

1. Tzioufas AG, Voulgarelis M (2007) Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21:989-1010 (Pubitemid 350194037)
2. Amarasena R, Bowman S (2007) Sjögren's syndrome. Clin Med 7:53-56
3. Routsias JG, Tzioufas AG (2007) Sjögren's syndrome - study of autoantigens and autoantibodies. Clinic Rev Allerg Immunol 32:238-251 (Pubitemid 350242570)
4. Asherson RA, Fei HM, Staub HL, Khamashta MA, Hughes GR, Fox RI (1992) Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis 51:495-498
5. Jedryka-Goral A, Jagiello P, D'Cruz DP et al (1992) Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis 51:889-891
6. Cervera R, García-Carrasco M, Font J et al (1997) Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 15:361-365 (Pubitemid 27323996)
7. Katayama Y, Kohriyama K, Kirizuka K, Nishizaki H, Fujii H, Tanji Y (2000) Sjögren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern Med 39:6-7
8. Ulvestad E, Kanestrom A, Tengnér P, Gjerde S, Sundal J, Haga HJ (2000) Anti-cardiolipin autoantibodies and pulmonary embolism. A case for a common cause. Scand J Rheumatol 29:330-333 (Pubitemid 32014854)
9. Wielosz E, Majdan M, Koszamy A, Zychowska I (2007) The overlap of primary Sjögren's syndrome with antiphospholipid syndrome in man: case report. Pol Arch Med Wewn 117:76
10. Fauchais A-L, Lambert M, Launay D et al (2004) Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13:245-248 (Pubitemid 38649623)
11. Petri M (2000) Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15:145-151
12. García-Carrasco M, Ramos-Casals M, Rosas J et al (2002) Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Med 81:270-280 (Pubitemid 34755936)
13. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309-1311 (Pubitemid 30265586)
14. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
15. Haga HJ, Jacobsen EM, Peen E (2008) Incidence of thromboembolic events in patients with primary Sjögren's syndrome. Scand J Rheumatol 37:127-129 (Pubitemid 351536083)
16. Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 69:1103-1109
17. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558 (Pubitemid 34539104)
18. Galanaud JP, Bosson JL, Quéré I (2011) Risk factors and early outcomes of patients with symptomatic distal vs. proximal deepvein thrombosis. Curr Opin Pulm Med 17:387-391
19. Sanz J, Fuster V (2011) The year in atherothrombosis. J Am Coll Cardiol 58:779-791
20. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM (2009) Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 61:29-36
21. Pierangeli SS, Harris EN (2005) Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 357:17-33 (Pubitemid 40823052)
22. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC, Standardization group of the European Forum on Antiphospholipid Antibodies (2004) Proposals for the measurement of anti-beta2- glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2:1860-1862
23. Wisloff F, Jacobsen EM, Liestol S (2002) Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 108:263-271 (Pubitemid 37025615)
24. Esparza RH, Swaak T, Aarden L, Smeenk R (1985) Complementfixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. J Rheumatol 12:1109-1117 (Pubitemid 16166454)
25. Mahler M, Stinton LM, Fritzler MJ (2005) Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of a SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol 12:107-113
26. Ruiz-Tíscar JL, López-Longo FJ, Sánchez-Ramón S et al (2005) Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome. Ann N Y Acad Sci 1050:210-216 (Pubitemid 41129438)
27. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (2010) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology (Oxford) 49:1590-1593
28. Bakker AJ, Slomp J, de Vries T et al (2003) Adequate sampling in cryoglobulinaemia: recommended warmly. Clin Chem Lab Med 41:85-89 (Pubitemid 36285390)
29. Juby AG, Davis P (1998) Prevalence and disease associations of certain autoantibodies in elderly patients. Clin Invest Med 21:4-11 (Pubitemid 28127823)
30. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN (1990) Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 20:231-236 (Pubitemid 20283041)
31. Biggioggero M, Meroni PL (2010) The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 9:A299- A304
32. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 8:998-1005
33. Theander E, Jacobsson LT (2008) Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 34:935-947
34. Palomo I, Segovia F, Ortega C, Pierangeli S (2009) Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. Clin Exp Rheumatol 27:668-677
35. Ramos-Casals M, Nardi N, Brito-Zerón P et al (2006) Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 35:312-321
36. Ramírez M, Ramos-Casals M, Graus F (2009) Central nervous system involvement in primary Sjögren syndrome. Med Clin (Barc) 133:349-359
37. Delalande S, de Seze J, Fauchais AL et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280-291 (Pubitemid 39258414)
38. He J, Guo JP, Ding Y et al (2011) Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome. Rheumatology (Oxford) 50:879-884